CVS Health Co. (NYSE:CVS) Shares Sold by Addison Capital Co

Addison Capital Co reduced its position in CVS Health Co. (NYSE:CVS) by 26.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,333 shares of the pharmacy operator’s stock after selling 6,236 shares during the quarter. Addison Capital Co’s holdings in CVS Health were worth $1,090,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CVS. First Community Trust NA grew its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health in the 3rd quarter valued at $33,000. Steph & Co. grew its holdings in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 288 shares in the last quarter. ORG Partners LLC grew its holdings in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group grew its holdings in shares of CVS Health by 71.0% during the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 247 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS stock opened at $59.49 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The firm has a market capitalization of $74.68 billion, a P/E ratio of 11.19, a P/E/G ratio of 0.93 and a beta of 0.54. The business’s 50-day moving average is $59.73 and its two-hundred day moving average is $60.75. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter last year, the company earned $2.21 EPS. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.47%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CVS shares. Wells Fargo & Company increased their price target on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Barclays upgraded CVS Health from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $63.00 to $82.00 in a report on Thursday, October 10th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lowered their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Truist Financial increased their price target on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.26.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.